Veklury (remdesivir)
Presence of Particulate Matter: Presence of glass particle.
Class I — High risk. Reasonable probability of serious harm or death.
Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.
Cause type: Particulate / foreign matter
Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.
Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2
Compare with the code on your package — it is the most precise check available.
From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.
| Product | Strength | Form & route | Labeler | Type |
|---|---|---|---|---|
| Veklury remdesivir NDC 61958-2901 |
100 mg/1 | Injection, Powder, Lyophilized, for Solution Intravenous |
Gilead Sciences, Inc. | Rx |
Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.
Presence of Particulate Matter: Presence of glass particle.
Defective Container; leaking around the cap
Presence of Foreign Substance: Truvada was found to contain small red silicone rubber particulates.
Presence of Foreign Substance: Red Silicone Rubber Particulates are Present in Drug.
Complaint received of foreign matter (metal) embedded in tablet.
Presence of Particulate Matter: Identified as Glass Particles
Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle
Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.